Literature DB >> 7196507

Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788.

P Polc, J P Laurent, R Scherschlicht, W Haefely.   

Abstract

This is an electrophysiological study in cats and rats of the imidazobenzodiazepinone derivative, Ro 15-1788, the first representative of specific benzodiazepine antagonists. (1) In unanaesthetized spinal cats, 1-10 mg kg-1 Ro 15-1788 i.v. did not affect segmental dorsal root potentials (DRPs), polysynaptic ventral root reflexes (VRRs), Renshaw cell responses to antidromic ventral root volleys and spontaneous gamma-motoneurone activity. However, at 1 mg kg-1 i.v., it antagonized the enhancement of DRPs as well as the depression of polysynaptic VRRs, Renshaw cell discharges and gamma-motoneurone activity induced by meclonazepam (0.1 mg kg-1 i.v.), diazepam (0.3 mg kg-1 i.v.) or zopiclone (1 mg kg-1 i.v.). The same dose of Ro 15-1788 failed to reduce similar effects of phenobarbital (10 mg kg-1 i.v.) on spinal cord activities. (2)In unanaesthetized "encéphale isole" rats, 3 mg kg-1 Ro 15-1788 i.v. abolished the decrease induced by 5 mg kg-1 midazolam i.v. of spontaneous multiunit activity (MUA) in the substantia nigra pars compacta, nucleus raphé dorsalis, nucleus locus coeruleus and the CAl area of the hippocampus dorsalis, but not the decrease produced by 10mg kg-1 pentobarbital i.v. Ro 15-1788 (12mg kg-1 i.v.) by itself did not affect MUA in the substantia nigra, but slightly depressed MUA in the other 3 areas. (3) In intact immobilized rats, the increase of power induced by 1 mg kg-1 flunitrazepam i.v. in the 0.5-48 Hz range of the electrocorticogram as well as in the 0.5-8 Hz, 8-32 Hz and 32-48 Hz frequency bands was transiently abolished by 5 mg kg-1 Ro 15-1788 i.v. (4) In unrestrained cats, 5 mg kg-1 Ro 15-1788 i.p. had no effect on the electrical threshold for eliciting a rage reaction evoked by electric hypothalamic stimulation, but abolished the threshold increase caused by 1 mg kg-1 diazepam i.p. These results are in line with biochemical and behavioural findings and support the selective antagonism by Ro 15-1788 of central effects of benzodiazepines through an interaction at benzodiazepine receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7196507     DOI: 10.1007/bf00501364

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors.

Authors:  J C Blanchard; A Boireau; C Garret; L Julou
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

2.  Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus.

Authors:  D W Gallager
Journal:  Eur J Pharmacol       Date:  1978-05-15       Impact factor: 4.432

3.  The hypothalamic "savage" syndrome.

Authors:  M Glusman
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1974

4.  Chlordiazepoxide induced beta spindle activity in rats.

Authors:  J I Székely; J Borsy; I Király
Journal:  Act Nerv Super (Praha)       Date:  1974-03

5.  The effect of diazepam on spinal cord activities: possible sites and mechanisms of action.

Authors:  P Polc; H Möhler; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Benzodiazepines attenuate single unit activity in the locus coeruleus.

Authors:  S J Grant; Y H Huang; D E Redmond
Journal:  Life Sci       Date:  1980-12-08       Impact factor: 5.037

7.  A quantitative electroencephalographic comparison of some benzodiazepines in the primate.

Authors:  R M Joy; A J Hance; K F Killam
Journal:  Neuropharmacology       Date:  1971-07       Impact factor: 5.250

8.  Effects of diazepines and barbiturates on hippocampal recurrent inhibition.

Authors:  P Wolf; H L Haas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

9.  Action of enpiprazole on emotional behavior induced by hypothalamic stimulation in rats and cats.

Authors:  M Murasaki; T Hara; T Oguchi; M Inami; Y Ikeda
Journal:  Psychopharmacology (Berl)       Date:  1976-09-29       Impact factor: 4.530

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  32 in total

Review 1.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

2.  The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects.

Authors:  A Higgitt; M Lader; P Fonagy
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Modulation and polytypic signaling in GABAergic transmission.

Authors:  J L Schlichting
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

4.  Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats.

Authors:  S J Cooper; D J Barber; D B Gilbert; W R Moores
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 5.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat.

Authors:  V Santucci; M Fournier; P Worms; P Keane; K Bizière
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration.

Authors:  J M Finlay; G Damsma; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.

Authors:  J W Mandema; M T Kuck; M Danhof
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

9.  Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects.

Authors:  E P Bonetti; L Pieri; R Cumin; R Schaffner; M Pieri; E R Gamzu; R K Müller; W Haefely
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  An Improved Process for the Synthesis of 4H-Imidazo[1,5-a][1,4]benzodiazepines.

Authors:  Jie Yang; Yun Teng; Shamim Ara; Sundari Rallapalli; James M Cook
Journal:  Synthesis (Stuttg)       Date:  2009-03       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.